AKI, albuminuria, eGFR considered separately or together can predict adverse outcomes in diabetes.
Kidney disease patients with macroalbuminuria were 86% more likely to be anemic.
Hyperkalemia occurred in just 1.8% of patients taking finerenone 7.5 to 20 mg daily.
The combination of eGFR and ACR outperformed most single traditional parameters for cardiovascular risk discrimination in patients with chronic kidney disease.
Investigators found the strongest associations for sepsis, followed by pneumonia and other lower respiratory tract infections.
Among patients with type 1 diabetes, incidence of proliferative retinopathy and persistent macroalbuminuria increased as average hemoglobin A1c rose.
For patients at high risk of cardiovascular disease, resting heart rate predicts renal outcomes singly and in combination.